Design and optimize N‐substituted EF 24 as effective and low toxicity NF ‐κB inhibitor for lung cancer therapy via apoptosis‐to‐pyroptosis switch-Reference-Cited by-同舟云学术

Design and optimize N‐substituted EF 24 as effective and low toxicity NF ‐κB inhibitor for lung cancer therapy via apoptosis‐to‐pyroptosis switch

Author:

Chen Liping¹,Li Qian¹,Zheng Zhiwei¹,Xie Jingwen¹,Lin Xiaoming²,Jiang Chengxi¹,Xu Haineng¹,Wu Xiaoping¹³,Wu Jianzhang¹^ORCID,Zhang Huajie¹

Affiliation:

1. Chemical Biology Research Center College of Pharmaceutical Sciences Wenzhou Medical University Wenzhou Zhejiang China

2. Department of Thoracic Surgery The First Affiliated Hospital of Whenzhou Medical University Wenzhou Zhejiang China

3. Institute of Tissue Transplantation and Immunology Jinan University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

Reference34 articles.

1. Michael acceptors as a tool for anticancer drug design;Ahn B. Z.;Current Pharmaceutical Design,1996

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献